Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Starpharma Holdings Ltd (SPHRY)

Starpharma Holdings Ltd (SPHRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Starpharma Holdings Ltd 4-6 Southampton Crescent Abbotsford C3 3072 AUS

www.starpharma.com P: 61-3-8532-2700

Description:

Starpharma Holdings Limited is engaged in the development of dendrimer products for pharmaceutical, life science and other applications. The Company's primary product in development is VivaGel, a microbicide gel for women used for the prevention and treatment of bacterial vaginosis and a range of sexually transmitted diseases. It also develops dendrimers as specialty chemicals for industrial applications. Starpharma Holdings Limited is headquartered in Melbourne, Australia.

Key Statistics

Overview:

Market Capitalization, $K 35,023
Enterprise Value, $K 14,563
Shares Outstanding, K 41,204
Annual Sales, $ 2,830 K
Annual Net Income, $ -10,530 K
EBIT, $ 0 K
EBITDA, $ -9,730 K
60-Month Beta 1.19
% of Institutional Shareholders 0.00%
Float, K 41,204
% Float 100.00%
Short Volume Ratio 0.41

Growth:

1-Year Return -74.63%
3-Year Return -94.79%
5-Year Return -89.38%
5-Year Revenue Growth -26.30%
5-Year Earnings Growth -17.39%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 10/05/23
Earnings Per Share ttm 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

SPHRY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -372.08%
Debt/Equity 0.14
Price/Sales 12.36
Price/Cash Flow N/A
Price/Book 1.49
Book Value/Share 0.57
Interest Coverage -1.09
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar